Web16 nov 2024 · Request PDF Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial Background ... Webjcog0501研究. s-1+顺铂新辅助治疗iv型和大iii型胃癌的iii期临床研究。 研究结论. 非印戒细胞组织学胃癌患者可从sp新辅助方案中获益; 鉴于良好的生存结果,即使组织学为印戒细胞型或腹腔细胞学阳性患者,仍推荐根治性手术序贯s-1 方案。 点评 【术后辅助化疗】
Phase II study of neoadjuvant chemotherapy with S-1 plus
Webまとめ. 切除可能な大型3型および4型胃癌に対して術前補助化学療法であるS-1+CDDP療法は推奨されず、根治切除+術後補助化学療法が標準治療のままである。. 本試験にお … WebBackground: Gastric cancer with extensive lymph node metastasis is commonly regarded as unresectable, while preoperative chemotherapy followed by gastrectomy has been tested since 2000 in JCOG (JCOG0001 and JCOG0405). The survivals were quite different between the trials despite the similar eligibility criteria. The aim of this study was … pbs dr fuhrman public television
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, …
http://www.jcog.jp/document/s_0501.pdf Web2 mar 2024 · Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501). Web8 lug 2024 · Yuya Sato, Takanobu Yamada, Takaki Yoshikawa, Ryunosuke Machida, Junki Mizusawa, Hiroshi Katayama, Masanori Tokunaga, Narikazu Boku, Masanori Terashima, Stomach Cancer Study Group/Japan Clinical Oncology Group, Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced … scripture on honoring the dead